Delivery Order SPE2DB20D2104-SPE2DB25FMWBK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Sirolimus 0.5 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $1,496.55. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Sirolimus is an immunosuppressant medication...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 6, 2025, for Sirolimus 1 mg tablets (100-count units) with a ceiling value of $1,454.80. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. This delivery order represents a child contract issued under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $2,919.60 to AmerisourceBergen Drug Corp for the supply of Sirolimus 0.5 mg tablets (100-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Sirolimus is an immunosuppressant medication commonly used in transplant and military...
- The Defense Logistics Agency awarded a delivery order valued at $1,287.56 to AmerisourceBergen Drug Corp for Sirolimus 0.5 mg tablets (100-count packages) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Sirolimus is an immunosuppressant medication commonly used in transplant medicine and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,872.18 to AmerisourceBergen Drug Corp for the supply of Sirolimus 1 mg/ml Solution in 60ml quantities. The contract, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the...
- The Defense Logistics Agency awarded a $499 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 tablets of 1 mg sirolimus. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of the pharmaceutical product to a facility in Conshohocken, Pennsylvania by September 19, 2023. The award is a firm fixed-price delivery order to the prime contractor, Amerisourcebergen, with no mention of major subcontractors. As...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sirolimus 1 mg/ml solution in 60 ml containers. The contract has a firm-fixed price of $2,432.75 and an ultimate completion date of May 28, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $4,196.80 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. AmerisourceBergen was awarded the delivery order to provide Sirolimus 1 mg/ml solution, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen, valued up to $999,999,999.00...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 tablets of the pharmaceutical product SIROLIMUS 2 MG. The $2,080.06 order has a completion date of December 22, 2023 and was placed without the use of a set-aside. Amerisourcebergen Drug Corp, through its Corporate Office division, has extensive experience as a prime contractor supplying pharmaceuticals, medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Everolimus 0.75 mg tablets (60-count) with a ceiling value of $6,624.37. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 11, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child order under a larger vehicle and carries no set-aside designation. This...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWBKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Sirolimus 0.5 mg tablets (100 count) with a ceiling value of $1,393.36. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract is scheduled for ultimate completion by July 23, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and systems worldwide. The company's contract portfolio demonstrates extensive experience fulfilling federal medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/22/25 |